Rachelle Jacques, President & Chief Executive Officer Earlier in her career, Ms. Jacques served in various roles at Dow Corning Corporation, including operational management positions in the U.S., Europe, and China. She serves on the boards of directors of uniQure N.V. (Nasdaq: QURE) and Corbus Pharmaceuticals (Nasdaq: CRBP) and is a founding member of the Alliance for Regenerative Medicine (ARM) Action for Equality Task Force. Ms. Jacques received her B.A. in business administration from Alma College and is currently a member of the school’s Board of Trustees. Contact: Rachelle.Jacques@akaritx.com John F. Neylan, III, MD, Executive Vice President, Chief Medical Officer Prior to joining industry, Dr. Neylan spent 12 years in academic medicine, progressing to Professor of Medicine at Emory University and Medical Director of the Emory Renal Transplant Program. He assumed numerous leadership positions in public policy and professional education, including the presidency of the American Society of Transplantation. Dr. Neylan completed a clinical fellowship in Nephrology and a research fellowship in Transplantation and Immunogenetics at Brigham & Women’s Hospital, Harvard University. Hecompleted his Internal Medicine residency at Vanderbilt University and received his M.D. from Rush Medical School.
Click to read bio
Click to read bio
Melissa Bradford-Klug, Chief Operating Officer Ms. Klug has a strong track record of successful fundraising, global acquisitions, licensing and development collaborations. Prior to joining Akari, Ms. Klug was President and Chief Business Officer at RareStone Group, where she led the identification and execution of strategic transactions for rare disease development programs for the China market. As co-founder and Chief Executive Officer of the women’s health startup Mayfield Pharmaceuticals (now Harrow Health), she created the company strategy, secured funding, drove clinical development and oversaw operations. She has held senior strategy and corporate/business development roles at Keryx Biopharmaceuticals, AMAG Pharmaceuticals, Mallinckrodt and Baxter International. She also has held commercial and research and development positions at Eli Lilly and Company and Monsanto. Ms. Klug is a member of the MassBio Board of Directors and Gender Diversity Committee and is a MassConnect mentor. She holds a Bachelor of Science degree in chemistry from Maryville University in St. Louis, Missouri and an MBA from DePaul University in Chicago, Illinois. Contact: Melissa.Klug@akaritx.com Torsten Hombeck, PhD, Chief Financial Officer Contact: Torsten.Hombeck@akaritx.com Dr. Miles Nunn, Chief Scientific Officer Contact: Miles.Nunn@akaritx.com
Click to read bio
Click to read bio
Click to read bio